We have developed a sensitive, simple and cheap method for determination of lipoic acid in urine and dietary
supplement tablets. The method is based on conversion of lipoic acid to its thiol counterpart – dihydrolipoic acid – by reductive
cleavage with tris(2-carboxyethyl)phosphine hydrochloride prior to precolumn derivatization with 1-benzyl-2-
chloropyridinium bromide, followed by ion-pairing reversed-phase liquid chromatography separation and ultraviolet detection
of its 2-S-pyridinium derivative at 321 nm. Bathochromic shift from the reagent absorption maximum at 275 nm to
that of derivative maximum at 321 nm, taking place during reaction, is analytically advantageous. In developing this
method the following parameters were investigated and optimized: the time, pH and reagent excess in the derivatization
step and mobile phase buffer concentration, pH, organic modifier and column temperature in the separation step. Calibration
plot, understood as the relationship between instrument response and known concentration of the analyte, demonstrated
linearity of results when applied to normal urine spiked with growing amounts of lipoic acid within the tested
range 0.2 – 50 µmol/L. The method was validated for urine samples received from healthy donors and urine concentration
of lipoic acid was monitored after oral administration of 600 mg of lipoic acid.
Keywords: Derivatization, determination, disulfide, HPLC, lipoic acid, thiol, urine.
Rights & PermissionsPrintExport